Connect your AI

Sanara MedTech Inc. SMTI Book value per share

Book value per share at other companies

IAR

Integra LifeSciencesIART

$13.55-32.0%

SolventumSOLV

$28.31+51.7%

Orthofix Medical Inc.OFIX

$10.76-8.0%

ClearPoint NeuroCLPT

$0.64-11.6%

Xtant Medical HoldingsXTNT

$0.35+13.4%

SI-BONE, Inc.SIBN

$4.07+3.0%

Other financials

Income statement

Revenue$27.8M+18.6%

Gross profit$25.9M+19.8%

Operating income$2.6M+221%

Net income$459.0K+113%

EPS (diluted)$0.05+112%

Balance sheet

Cash & equivalents$13.6M-34.3%

Total debt$48.4M+8.2%

Total equity$7.0M-80.8%

Total assets$69.3M-28.1%

Cash flow

Operating cash flow-$2.5M-23.3%

CapEx$43.8K-97.5%

Free cash flow-$2.5M+32.6%

Valuation

Market cap$216.18M-9.7%

Enterprise value$250.95M-6.5%

P/S2×-0.5×

Profitability

Gross margin92.9%+1.8pp

Operating margin6.1%+5.1pp

Net margin-31.2%-93.4pp

FCF margin-9.8%-3.5pp

Returns & leverage

Return on equity-153.7%-199pp

Debt / equity6.9×+5.7×

Current ratio2.3×-0.5×

Where this comes from

Calculated from Sanara MedTech Inc.’s reported figures.

total stockholders equity/weighted shares diluted=$0.78

Based on the most recent quarter.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Sanara MedTech Inc.'s book value per share?: Sanara MedTech Inc. (SMTI) reported book value per share of $0.78 in Q1 2026.
How has Sanara MedTech Inc.'s book value per share changed year-over-year?: Sanara MedTech Inc.'s book value per share decreased by 81.7% year-over-year, from $4.28 to $0.78.
What is the long-term trend for Sanara MedTech Inc.'s book value per share?: Over 5 years (2020 to 2025), Sanara MedTech Inc.'s book value per share has grown at a -8.5% compound annual growth rate (CAGR), from $1.07 to $0.69.
What does book value per share mean?: Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.